Mutation spectrum in HNPCC in the Israeli population

Familial Cancer

Volumn 7, Issue 4, 2008, Pages 309-317

  Goldberg, Yael ^a   Porat, Rinnat M ^a   Kedar, Inbal ^b   Shochat, Chen ^c   Sagi, Michal ^a   Eilat, Avital ^a   Mendelson, Suzan ^a   Hamburger, Tamar ^a   Nissan, Aviram ^a   Hubert, Ayala ^a   Kadouri, Luna ^a   Pikarski, Eli ^a   Lerer, Israela ^a   Abeliovich, Dvorah ^a   Bercovich, Dani ^c,d   Peretz, Tamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^d TEL HAI COLLEGE   (Israel)

Author keywords

Ashkenazi; Colorectal cancer; HNPCC; Israeli; Lynch; MMR; MSI; Oncogenetic

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLON CANCER; COLON POLYPOSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE INSERTION SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HEREDITARY NONPOLYPOSIS COLON CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; ISRAEL; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; ALGORITHMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; FEMALE; HUMANS; ISRAEL; JEWS; MALE; MUTATION; PEDIGREE; POPULATION GROUPS; RETROSPECTIVE STUDIES;

EID: 55949091468     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-008-9191-y     Document Type: Article

References (33)

1. Gentests: http://www.geneclinics.org/servlet/access?db= geneclinics&site=gt&id=8888892&key=oqc5FWFw5cxp&gry=&fcn= y&fw=699B&filename=/profiles/hnpcc/index.html
2. HT Lynch A de la Chapelle 2003 Hereditary colorectal cancer N Engl J Med 348 919 932
3. I Dove-Edwin P Sasieni J Adams 2005 Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study BMJ 331 7524 1047
4. HJ Järvinen M Aarnio H Mustonen 2000 Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 829 834
5. A De la Chapelle 2003 Microsatellite instability N Engl J Med 349 3 209 210
6. CR Boland SN Thibodeau SR Hamilton 1998 A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 22 5248 5257
7. N Suraweera A Duval M Reperant 2002 Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR Gastroenterology 123 6 1804 1811
8. M Aarnio R Sankila E Pukkala 1999 Cancer risk in mutation carriers of DNA mismatch-repair genes Int J Cancer 81 2 214 218
9. Chen S et al (2006) Prediction of germline mutations and cancer risk in the lynch syndrome JAMA 296:1479-1487
10. MA Rodriguez-Bigas CR Boland 1997 A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines J Natl Cancer Inst 89 1758 1762
11. A Umar CR Boland JP Terdiman 2004 Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 261 268
12. J Wijnen H van der Klift H Vasen 1998 MSH2 genomic deletions are a frequent cause of HNPCC Nat Genet 20 326 328
13. A Wagner A Barrows JT Wijnen 2003 Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomia deletion of the MSH2 gene Am J Hum Genet 72 1088 1100
14. F Marroni C Pastrello P Benatti 2006 A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability Clin Genet 69 3 254 262
15. Banjerjee SK, Maldisi WF, Weston AP et al (1995) Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification. BioTechniques 18(5):768-773
16. M Fujita 1995 Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer Int J Cancer 64 6 361 366
17. D Bercovich AL Beaudet 2003 Denaturing high-performance liquid chromatography for the detection of mutations and polymorphisms in UBE3A Genet Test 7 3 189 194
18. B Wolf S Henglmueller E Janschek 2005 Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer Wien Klin Wochenschr 117 7-8 269 277
19. Sheng JQ, Chan TL, Chan YW et al (2006) Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Chin J Dig Dis 7(4):197-205
20. S Glasl 2000 Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC) Hum Mutat 16 1 91 92
21. Wijnen J et al (1997) Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 61(2):329-335
22. Fidder HH et al (2005) Genetic analyses in consecutive Israeli Jewish colorectal cancer patients. Am J Gastroenterol 100(6):1376
23. A Apessos M Mihalatos I Danielidis 2005 hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients Br J Cancer 92 2 396 404
24. Peterlongo P et al (2003) MSH6 germline mutations are rare in colorectal cancer families. Int J Cancer 107(4):571-579
25. Lindor NM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293(16):1979-1985
26. Vasen HFA et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353-362
27. de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. Correspondence re: A. Muller et al (2003) Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 63(5):1148-1149
28. Vahteristo P et al (2005) No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer. J Med Genet 42(4):e22
29. YM Hendriks 2006 Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians CA Cancer J Clin 56 4 213 225
30. W Foulkes I Thiffault SB Gruber 2002 The Founder Mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish Population Am J Hum Genet 71 6 1395 1412
31. Sun S et al (2005). The HNPCC associated MSH2*1906G C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population. J Med Genet 42:766-768
32. JG Guillem 2004 A636P testing in Ashkenazi Jews Fam Cancer 3 3-4 223 227
33. Shiri-Sverdlov R et al (2000) Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Hum Mutat 16(6):491-501